Bifidobacterium Animalis Subsp. Lactis Fermented Milk Product Reduces Inflammation by Altering a Niche for Colitogenic Microbes

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2010 Oct 6

PMID 20921388

Citations 112

Authors

Patrick Veiga

Carey Ann Gallini

Chloe Beal

Monia Michaud

Mary L Delaney

Andrea DuBois

Artem Khlebnikov

Johan E T van Hylckama Vlieg

Shivesh Punit

Jonathan N Glickman

Andrew Onderdonk

Laurie H Glimcher

Wendy S Garrett

Affiliations

Soon will be listed here.

Abstract

Intestinal health requires the coexistence of eukaryotic self with the gut microbiota and dysregulated host-microbial interactions can result in intestinal inflammation. Here, we show that colitis improved in T-bet(-/-)Rag2(-/-) mice that consumed a fermented milk product containing Bifidobacterium animalis subsp. lactis DN-173 010 strain. A decrease in cecal pH and alterations in short chain fatty acid profiles occurred with consumption, and there were concomitant increases in the abundance of select lactate-consuming and butyrate-producing bacteria. These metabolic shifts created a nonpermissive environment for the Enterobacteriaceae recently identified as colitogenic in a T-bet(-/-)Rag2(-/-) ulcerative colitis mouse model. In addition, 16S rRNA-based analysis of the T-bet(-/-)Rag2(-/-) fecal microbiota suggest that the structure of the endogenous gut microbiota played a key role in shaping the host response to the bacterial strains studied herein. We have identified features of the gut microbiota, at the membership and functional level, associated with response to this B. lactis-containing fermented milk product, and therefore this model provides a framework for evaluating and optimizing probiotic-based functional foods.

Citing Articles

Impact of Fermented Milk On Gut Microbiota And Human Health: A Comprehensive Review.

Abd El-Salam M, El-Shibiny S, Assem F, El-Sayyad G, Hasanien Y, Elfadil D Curr Microbiol. 2025; 82(3):107.

PMID: 39888432 DOI: 10.1007/s00284-025-04061-z.

Alteration of the Gut-Lung Axis After Severe COVID-19 Infection and Modulation Through Probiotics: A Randomized, Controlled Pilot Study.

Horvath A, Habisch H, Prietl B, Pfeifer V, Balazs I, Kovacs G Nutrients. 2024; 16(22).

PMID: 39599626 PMC: 11597208. DOI: 10.3390/nu16223840.

Impact of low FODMAP sourdough bread on gut microbiota using an colonic fermentation model.

Koc F, Arendt E, Coffey A, Ross R, Stanton C Front Microbiol. 2024; 15:1496022.

PMID: 39588097 PMC: 11586379. DOI: 10.3389/fmicb.2024.1496022.

lefser: implementation of metagenomic biomarker discovery tool, LEfSe, in R.

Khleborodova A, Gamboa-Tuz S, Ramos M, Segata N, Waldron L, Oh S Bioinformatics. 2024; 40(12).

PMID: 39585730 PMC: 11665633. DOI: 10.1093/bioinformatics/btae707.

The effects of dairy on the gut microbiome and symptoms in gastrointestinal disease cohorts: a systematic review.

Ni Chonnachain C, Feeney E, Gollogly C, Shields D, Loscher C, Cotter P Gut Microbiome (Camb). 2024; 5:e5.

PMID: 39290657 PMC: 11406376. DOI: 10.1017/gmb.2024.2.

References

Vijay-Kumar M, Aitken J, Carvalho F, Cullender T, Mwangi S, Srinivasan S . Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010; 328(5975):228-31. PMC: 4714868. DOI: 10.1126/science.1179721. View

Sokol H, Seksik P, Furet J, Firmesse O, Nion-Larmurier I, Beaugerie L . Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009; 15(8):1183-9. DOI: 10.1002/ibd.20903. View

Carvalho F, Barnich N, Sivignon A, Darcha C, Chan C, Stanners C . Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med. 2009; 206(10):2179-89. PMC: 2757893. DOI: 10.1084/jem.20090741. View

RHOADES E, Short S . Susceptibility of Serratia, Pseudomonas, and Enterobacter to acetic acid. Antimicrob Agents Chemother (Bethesda). 1970; 10:498-502. DOI: 10.1128/AAC.10.3.498. View

Matsuda K, Tsuji H, Asahara T, Matsumoto K, Takada T, Nomoto K . Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol. 2009; 75(7):1961-9. PMC: 2663197. DOI: 10.1128/AEM.01843-08. View

Cherrington C, Hinton M, Pearson G, Chopra I . Short-chain organic acids at ph 5.0 kill Escherichia coli and Salmonella spp. without causing membrane perturbation. J Appl Bacteriol. 1991; 70(2):161-5. DOI: 10.1111/j.1365-2672.1991.tb04442.x. View

Macfarlane G, Blackett K, Nakayama T, Steed H, Macfarlane S . The gut microbiota in inflammatory bowel disease. Curr Pharm Des. 2009; 15(13):1528-36. DOI: 10.2174/138161209788168146. View

Turnbaugh P, Hamady M, Yatsunenko T, Cantarel B, Duncan A, Ley R . A core gut microbiome in obese and lean twins. Nature. 2008; 457(7228):480-4. PMC: 2677729. DOI: 10.1038/nature07540. View

Gibson G, Roberfroid M . Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995; 125(6):1401-12. DOI: 10.1093/jn/125.6.1401. View

10.

Belenguer A, Duncan S, Calder A, Holtrop G, Louis P, Lobley G . Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol. 2006; 72(5):3593-9. PMC: 1472403. DOI: 10.1128/AEM.72.5.3593-3599.2006. View

11.

Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B . Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology. 2004; 126(2):520-8. DOI: 10.1053/j.gastro.2003.11.019. View

12.

Frank D, St Amand A, Feldman R, Boedeker E, Harpaz N, Pace N . Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007; 104(34):13780-5. PMC: 1959459. DOI: 10.1073/pnas.0706625104. View

13.

Sommer M, Dantas G, Church G . Functional characterization of the antibiotic resistance reservoir in the human microflora. Science. 2009; 325(5944):1128-1131. PMC: 4720503. DOI: 10.1126/science.1176950. View

14.

Roediger W . Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut. 1980; 21(9):793-8. PMC: 1419533. DOI: 10.1136/gut.21.9.793. View

15.

Watterlot L, Rochat T, Sokol H, Cherbuy C, Bouloufa I, Lefevre F . Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. Int J Food Microbiol. 2010; 144(1):35-41. DOI: 10.1016/j.ijfoodmicro.2010.03.037. View

16.

Makivuokko H, Saarinen M, Ouwehand A, Rautonen N . Effects of lactose on colon microbial community structure and function in a four-stage semi-continuous culture system. Biosci Biotechnol Biochem. 2006; 70(9):2056-63. DOI: 10.1271/bbb.60022. View

17.

de Moreno de LeBlanc A, Perdigon G . The application of probiotic fermented milks in cancer and intestinal inflammation. Proc Nutr Soc. 2010; 69(3):421-8. DOI: 10.1017/S002966511000159X. View

18.

Hill D, Hoffmann C, Abt M, Du Y, Kobuley D, Kirn T . Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol. 2009; 3(2):148-58. PMC: 2824244. DOI: 10.1038/mi.2009.132. View

19.

Garrett W, Lord G, Punit S, Lugo-Villarino G, Mazmanian S, Ito S . Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell. 2007; 131(1):33-45. PMC: 2169385. DOI: 10.1016/j.cell.2007.08.017. View

20.

Roe A, OByrne C, McLaggan D, Booth I . Inhibition of Escherichia coli growth by acetic acid: a problem with methionine biosynthesis and homocysteine toxicity. Microbiology (Reading). 2002; 148(Pt 7):2215-2222. DOI: 10.1099/00221287-148-7-2215. View